bromodeoxyuridine has been researched along with Breast Neoplasms in 131 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (9.92) | 18.7374 |
| 1990's | 61 (46.56) | 18.2507 |
| 2000's | 39 (29.77) | 29.6817 |
| 2010's | 16 (12.21) | 24.3611 |
| 2020's | 2 (1.53) | 2.80 |
| Authors | Studies |
|---|---|
| Czerwonka, A; Luszczki, J; Okon, E; Telejko, I; Wawruszak, A | 1 |
| Lang, Z; Liu, H; Liu, J; Ma, L; Wang, M; Zhang, H | 1 |
| Che, D; Dai, Z; Gao, G; Li, C; Li, L; Li, S; Ma, J; Yang, X; Yao, Y; Zhou, T | 1 |
| Alontaga, AY; Ashby, J; Chandra, M; Chen, Y; Chin, AR; Chow, A; Fong, MY; Kong, M; Li, S; Li, Z; Liu, L; O'Connor, ST; Palomares, M; Reid, MA; Ren, X; Shi, Y; Somlo, G; Sun, G; Swiderski, P; Tremblay, JR; Tsuyada, A; Wang, SE; Wu, X; Zhong, W; Zhou, W | 1 |
| Casbon, AJ; Gan, DD; Khuc, E; Park, C; Passegué, E; Reynaud, D; Schepers, K; Werb, Z | 1 |
| Brockhoff, G; Diermeier-Daucher, S; Hasmann, M | 1 |
| Alm, K; Johansson, M; Myhre, L; Oredsson, SM | 1 |
| Chen, Z; Han, Z; Liu, F; Lu, S; Ren, H; Ren, Q; Zhang, L; Zhao, Q | 1 |
| Beattie, CW; Bratescu, L; Christov, K; Das Gupta, TK; Green, A; King, ML; Lekmine, F; Majumdar, D; Mehta, RR; Shilkaitis, A; Yamada, T | 1 |
| Baena-Cañada, JM; García-Olmedo, O; Jiménez-Bárcenas, R; Martínez, MJ; Muriel-Cueto, P | 1 |
| Brentani, MM; Folgueira, MA; Katayama, ML; Lyra, EC; Maciel, MS; Milani, C; Welsh, J | 1 |
| Gregoraszczuk, EL; Mazur, K; Ptak, A | 1 |
| Chow, D; Garand, C; Guay, D; Langlois, M; Lebel, M; Perreault, E; Sereduk, C; Tsofack, SP; Yin, HH | 1 |
| Ali, S; Khan, HA; Naime, M; Sajad, M; Umar, S; Zargan, J | 1 |
| Bugyik, E; Dezso, K; Döme, B; Klepetko, W; László, V; Nagy, P; Paku, S; Reiniger, L; Tímár, J; Tóvári, J | 1 |
| Ambs, S; Dorsey, TH; Frerich, K; Garza, JG; Glynn, SA; Hunt, KK; Johanning, GL; Li, M; Lin, K; Plummer, JB; Rycaj, K; Shen, J; Wang-Johanning, F; Yan, P; Yin, B | 1 |
| Acharya, MM; Christie, LA; Limoli, CL; Martirosian, V; Nguyen, A; Parihar, VK | 1 |
| Balzarini, J; Gago, F; Liekens, S; Vande Voorde, J; Vrancken, K | 1 |
| Gu, M; Ma, S; Zhang, NQ; Zhao, L; Zheng, XY | 1 |
| Martin, KR; Wooden, A | 1 |
| Cai, X; Dong, X; He, A; Sun, Y; Xu, K; Zhang, N; Zheng, C; Zheng, X | 1 |
| Barberi-Heyob, M; Didelot, C; Merlin, JL; Mirjolet, JF | 1 |
| Barcellos-Hoff, MH; Bissell, MJ; Hansen, RK; Petersen, OW; Radisky, D; Turley, EA; Wang, F; Yoneda, T | 1 |
| Brueggemeier, RW; Petrel, TA | 1 |
| Beryt, M; Boyer, CR; Karjian, PL; Neuteboom, ST; Pegram, M; Shepard, HM; Wahl, GM | 1 |
| Aguirre, A; Diáz-González, F; Dorta, J; Fernández, JJ; Moser-Thier, K; Pec, MK; Souto, ML; Villar, J | 1 |
| Dellinger, RW; Karjian, PL; Neuteboom, ST | 1 |
| Manabe, Y; Miyazaki, K; Sugihara, H; Toda, S | 1 |
| Brockhoff, G; Diermeier, S; Kubbies, M; Kunz-Schughart, LA; Schmidt-Bruecken, E | 1 |
| Arteaga, CL; Dumont, N; Koh, Y; Ueda, Y; Wang, S; Yi, JY | 1 |
| Kozubík, A; Machala, M; Plísková, M; Vojtesek, B; Vondrácek, J | 1 |
| Holst, U; Johansson, M; Larsson, S; Oredsson, S | 1 |
| Alvarez, C; Glass, A; Lister, K; Meyer, JS; Milikowski, C; Olson, N; Parwaresch, R; Russo, I; Russo, J; Zehnbauer, BA | 1 |
| Boerner, JL; Fox, EM; Gibson, MA; Parsons, SJ; Posner, ED; Shupnik, MA; Silva, CM | 1 |
| Ho, CT; Huang, MT; Lin, CC; Lu, YP; Teng, SC; Tsai, YL; Tseng, SF | 1 |
| Biscardi, JS; Boerner, JL; Parsons, SJ; Silva, CM | 1 |
| Tannock, IF; Wu, L | 1 |
| Chellappan, S; Mehta, R; Mehta, RG; Peng, X; Wang, S | 1 |
| Goodson, WH; Moore, DH; Waldman, FM | 1 |
| Cardiff, RD; Chou, YC; Shyamala, G; Vargis, E | 1 |
| Estes, NR; Kern, FG; Thottassery, JV; Westbrook, L | 1 |
| Fornelli, F; Leone, A; Minervini, F; Verdesca, I; Zacheo, G | 1 |
| Chou, TC; Gallo, MA; Nair, SK; Shirahata, A; Thomas, T; Thomas, TJ; Verma, A | 1 |
| Jing, J; Lin, P; Ren, JJ; Wang, J; Wang, XJ; Wu, YY; Xiong, ZJ; Yang, HL; Zhang, J; Zheng, H | 1 |
| Brockhoff, G; Diermeier, S; Heckel, B; Hofstaedter, F; Plander, M; Schmidt-Bruecken, E; Vollmann, A | 1 |
| Cai, D; Eckstein, N; Gazdar, AF; Girard, L; Jaehde, U; Kassack, MU; Minna, JD; Royer, HD; Servan, K; von Jonquieres, G | 1 |
| Qiao, L; Shan, CL; Wang, FZ; Ye, LH; Zhang, XD; Zhao, TJ | 1 |
| Fillmore, CM; Kuperwasser, C | 1 |
| Alm, K; Hegardt, C; Jönsson, G; Larsson, S; Myhre, L; Oredsson, SM; Staaf, J | 1 |
| Akisue, G; Barbuto, JA; Cogliati, B; da Silva, TC; Dagli, ML; Górniak, SL; Haraguchi, M; Matsuzaki, P; Nagamine, MK; Pinello, KC; Pizzo, CR; Rao, KV; Sinhorini, IL | 1 |
| Gratzner, H; Hsu, SM; Kinsella, T; Mitchell, J; Morstyn, G; Russo, A | 1 |
| Kaung, HL; Trend, B; Wang, N; Wang, T | 1 |
| Horwitz, KB; Lessey, BA; Mockus, MB | 1 |
| Garcia, M; Rochefort, H; Westley, B | 1 |
| André, J; Baskevitch, PP; Kallos, J; Rochefort, H; Vignon, F; Westley, B | 1 |
| Hofland, LJ; Lamberts, SW; Sprij, DM; van der Burg, B; van Eijck, CH; van Koetsveld, PM | 1 |
| Gray, C; Lange, M; Mannell, A; Mohube, P; Myburgh, JA; Teare, J; Winters, Z; Wright, C | 1 |
| Bicknell, R; Cooke, TG; Fox, SB; Gatter, KC; Going, JJ; Harris, AL; Stanton, P | 1 |
| Birtwisle, I; Caldani, C; Courdi, A; Ettore, F; Gioanni, J; Namer, M; Rostagno, P | 1 |
| Chew, KL; Christov, K; Goodson, WH; Ljung, BM; Mayall, BH; Smith, HS; Waldman, FM | 1 |
| Danova, M; Gibelli, N; Giordano, M; Mangiarotti, R; Mazzini, G; Pellicciari, C; Riccardi, A; Wang, E; Zibera, C | 1 |
| He, W; Hughes, J; Koehm, S; Meyer, JS; Scrivner, DL | 1 |
| He, W; Meyer, JS | 1 |
| Akedo, Y; Hosoi, T; Ikegami, A; Inoue, S; Kaneki, M; Mizuno, Y; Orimo, H; Ouchi, Y | 1 |
| Garin-Chesa, P; Lloveras, B; Melamed, M; Myc, A | 1 |
| Bernardi, A; Caldarola, B; Calderini, P; Cappa, AP; Gaglia, P; Lauro, D; Liscia, DS; Venesio, T | 1 |
| Chew, K; Goodson, WH; Ljung, BM; Mayall, B; Moore, DH; Smith, HS; Waldman, FM; Weidner, N | 1 |
| Cooke, TG; Going, JJ; Stanton, PD | 1 |
| Higa, E; Hughes, JM; Koehm, SL; Lagos, JA; Manes, JL; Meyer, JS; Wittliff, JL | 1 |
| Benz, CC; Chew, K; Goodson, WH; Ljung, BM; Mayall, B; Moore, DH; Smith, HS; Waldman, FM | 1 |
| Bottone, MG; Danova, M; Mangiarotti, R; Pellicciari, C; Wang, E | 1 |
| Cooke, TG; Forster, G; Going, JJ; Smith, D; Stanton, PD | 1 |
| Hara, H; Moriki, T; Takahashi, T; Tanioka, F; Yamane, T | 1 |
| Hara, H; Hiroi, M; Moriki, T; Takahashi, T; Yamane, T | 1 |
| Borgers, M; Bruwiere, H; de Jong, P; Ramaekers, F; Smets, G; Van Heusden, J | 1 |
| Baldetorp, B; Bendahl, PO; Fadeel, IA; Johansson, MC; Oredsson, SM | 1 |
| Hara, H; Hiroi, M; Kataoka, H; Moriki, T; Takahashi, T; Yamane, T | 1 |
| Pozharisskiĭ, KM; Semiglazov, VF; Tsyrlina, EV; Uporov, AV | 1 |
| Calberg-Bacq, CM; Grignet-Debrus, C | 1 |
| Chew, K; Chu, L; Isola, J; Kallioniemi, A; Nishizaki, T; Waldman, FM; Weidner, N | 1 |
| Baldetorp, B; Borg, A; Hedenfalk, IA; Oredsson, SM | 1 |
| Beyer, U; Cazabat, A; Collery, P; Falken, U; Kratz, F; Lechenault, F; Schumacher, P; Unger, C | 1 |
| Hood, CJ; Parham, DM | 1 |
| Anderson, BO; Creason, S; Hockenbery, D; Knowlton, K; Mancini, M; Morales, C | 1 |
| Chew, K; Florendo, C; Goodson, WH; Ljung, BM; Mayall, B; Moore, DH; Smith, HS; Waldman, FM | 1 |
| Reeve, LJ; Rew, DA; Wilson, GD | 1 |
| Filie, AC; Hanfelt, J; Kern, FG; McLeskey, SW; Tobias, CA; Vezza, PR | 1 |
| Edgerton, SM; Liu, S; Moore, DH; Thor, AD | 1 |
| El-Deiry, WS; Mitchell, KO | 1 |
| Birtwisle-Peyrottes, I; Ettore, F; Formento, JL; Granon, C; Moll, JL; Rostagno, P | 1 |
| de Jong, JM; Engelen, JJ; Kleinjans, JC; Schilderman, PA; Welle, IJ; Zwingmann, IH | 1 |
| Baldetorp, B; Johansson, MC; Oredsson, SM | 1 |
| Balzarini, J; Baudson, N; Calberg-Bacq, CM; Cool, V; De Leval, L; Debrus, S; Degrève, B; Grignet-Debrus, C; Velu, T | 1 |
| Chew, K; Goodson, WH; Ljung, BM; Mayall, B; Moore, DH; Smith, HS; Waldman, FM | 1 |
| Creminon, C; Hla, T; Huang, CK; Jang, BC; Liu, CH; Sanchez, T; Schaefers, HJ; Trifan, OC | 1 |
| Cutress, RI; Mullee, MA; Rew, DA; Royle, GT | 1 |
| Ahamed, S; Bukovsky, A; Foster, JS; Wimalasena, J | 1 |
| Conneely, OM; Gay, J; Hilsenbeck, SG; Medina, D; O'Malley, BW; Sivaraman, L; Zhong, L | 1 |
| Boyer, CR; Karjian, PL; Neuteboom, ST; Pegram, M; Wahl, GM | 1 |
| Munzenrider, JE | 1 |
| Bokhari, SA; Miller, MA; Qadir, K; Raza, A | 1 |
| Buley, ID; Gatter, KC; Horak, E; Kaklamanis, L; Morrison, EH | 1 |
| Berry, JP; Chassoux, D; Escaig, F; Galle, P; Lespinats, G; Linarez-Cruz, LG | 1 |
| Matsumura, K; Murakami, T; Sasaki, K; Tsuji, T | 1 |
| Campbell, ID; Rew, DA; Taylor, I; Wilson, GD | 1 |
| Cornelisse, CJ; Keijzer, R; van de Velde, CJ; van Dierendonck, JH; Wijsman, JH | 1 |
| Chew, K; Duarte, LA; Goodson, W; Hom, J; Ljung, BM; Mayall, B; Smith, HS; Waldman, FM | 1 |
| Bernardi, A; Callahan, R; Canale, L; Cappa, AP; Gaglia, P; Lauro, D; Liscia, DS; Merlo, GR; Venesio, T | 1 |
| Balazs, M; Mayall, BH; Waldman, FM | 2 |
| Dutrillaux, B; Gerbault-Seureau, M; Prieur, M; Zafrani, B | 1 |
| Going, JJ | 1 |
| Benyahia, B; Magdelénat, H; Padoy, E; Remvikos, Y; Vielh, P; Voillemot, N | 1 |
| Benz, C; Chew, K; Goldman, ES; Goodson, WH; Ljung, BM; Mayall, B; Moore, DH; Smith, H; Waldman, F | 1 |
| Guillaud, P; Seigneurin, D; Vermont, J | 1 |
| Cassanelli, S; Guillaud, P; Louis, J; Seigneurin, D | 1 |
| Cancellieri, A; Ceccarelli, C; Derenzini, M; Eusebi, V; Farabegoli, F; Trerè, D | 1 |
| Edgerton, S; Lloveras, B; Thor, AD | 1 |
| Bush, C; Parkins, CS; Price, P; Steel, GG | 1 |
| Dauvois, S; de Launoit, Y; Dufour, M; Labrie, F; Simard, J | 1 |
| Chew, KL; Christov, K; Duarte, LA; Goodson, WH; Ljung, BM; Mayall, BH; Smith, HS; Waldman, FM | 1 |
| Bosman, FT; De Goij, AF; Scheres, HM; Schutte, B | 1 |
| Bontenbal, M; Foekens, JA; Klijn, JG; Peters, HA; Sieuwerts, AM; Sonneveld, P | 1 |
| Armstrong, B; Hannigan, BM; McKenna, PG; Modjtahedi, H; O'Neill, KL | 1 |
| Barlogie, B; Kute, TE; McGuire, Wl; Meyer, JS | 1 |
| Berry, JP; Boumati, P; Cavellier, JF; Escaig, F; Galle, P; Lespinats, G; Tlouzeau, S | 1 |
| Cho, EK; Chung, CH; Lee, SS; Lee, TS; Park, JS | 1 |
| Hughes, J; Koehm, S; Meyer, JS; Nauert, J | 1 |
| Bruno, S; Di Vinci, A; Geido, E; Giaretti, W | 1 |
| Gunduz, N | 1 |
| Takakura, K | 1 |
2 review(s) available for bromodeoxyuridine and Breast Neoplasms
| Article | Year |
|---|---|
Interaction between capecitabine and brivudin in a patient with breast cancer.
Topics: Aged; Anemia, Aplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Breast Neoplasms; Bromodeoxyuridine; Capecitabine; Carcinoma, Ductal, Breast; Combined Modality Therapy; Deoxycytidine; Dihydrouracil Dehydrogenase (NADP); Drug Interactions; Fatal Outcome; Female; Fluorouracil; Herpes Zoster; Humans; Onycholysis; Palliative Care; Peripheral Nervous System Diseases; Salvage Therapy; Stomatitis; Tooth Discoloration | 2010 |
Recent advances in radiotherapy.
Topics: Breast Neoplasms; Bromodeoxyuridine; Carcinoid Tumor; Elementary Particles; Fast Neutrons; Hot Temperature; Humans; Male; Melanoma; Metronidazole; Neoplasms; Nitroimidazoles; Pancreatic Neoplasms; Prostatic Neoplasms; Protons; Radiation Protection; Radiation Tolerance; Radiation-Sensitizing Agents; Radioisotopes; Radiotherapy Dosage; Radiotherapy, High-Energy; Rectal Neoplasms; Salivary Gland Neoplasms; Sarcoma; Soft Tissue Neoplasms | 1977 |
1 trial(s) available for bromodeoxyuridine and Breast Neoplasms
| Article | Year |
|---|---|
Immunohistochemical determination of nuclear antigens by colour image analysis: application for labelling index, estrogen and progesterone receptor status in breast cancer.
Topics: Antigens, Neoplasm; Breast Neoplasms; Bromodeoxyuridine; Color; Humans; Image Processing, Computer-Assisted; Immunoenzyme Techniques; Nuclear Proteins; Receptors, Estrogen; Receptors, Progesterone; Reproducibility of Results; Sensitivity and Specificity; Thymidine | 1994 |
128 other study(ies) available for bromodeoxyuridine and Breast Neoplasms
| Article | Year |
|---|---|
Additive pharmacological interaction between sirtuin inhibitor cambinol and paclitaxel in MCF7 luminal and MDA-MB-231 triple-negative breast cancer cells.
Topics: Apoptosis; Breast Neoplasms; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Female; Histone Deacetylase Inhibitors; Humans; Paclitaxel; Sirtuins; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays | 2022 |
MiR-135a-5p suppresses breast cancer cell proliferation, migration, and invasion by regulating BAG3.
Topics: 3' Untranslated Regions; Adaptor Proteins, Signal Transducing; Apoptosis Regulatory Proteins; Breast Neoplasms; Bromodeoxyuridine; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Proto-Oncogene Proteins c-bcl-2; TOR Serine-Threonine Kinases; Transforming Growth Factor beta | 2022 |
High metastaticgastric and breast cancer cells consume oleic acid in an AMPK dependent manner.
Topics: Adipocytes; AMP-Activated Protein Kinases; Analysis of Variance; Azo Compounds; Blotting, Western; Breast Neoplasms; Bromodeoxyuridine; Cell Line, Tumor; Cell Movement; Cell Survival; Enzyme Activation; Female; Humans; Neoplasm Metastasis; Oleic Acid; Oxygen Consumption; Stomach Neoplasms; Triglycerides | 2014 |
Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis.
Topics: Astrocytes; Base Sequence; Breast Neoplasms; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Exosomes; Female; Fibroblasts; Glucose; Humans; Luciferases; Lung; MicroRNAs; Molecular Sequence Data; Neoplasm Metastasis; Pyruvate Kinase | 2015 |
Invasive breast cancer reprograms early myeloid differentiation in the bone marrow to generate immunosuppressive neutrophils.
Topics: Animals; Breast Neoplasms; Bromodeoxyuridine; Cell Line, Tumor; Female; Flow Cytometry; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Immune Tolerance; Mice; Mice, Inbred C57BL; Mice, Knockout; Myeloid Cells; Neoplasm Invasiveness; Neutrophils; Receptors, Granulocyte Colony-Stimulating Factor | 2015 |
Flow cytometric FRET analysis of erbB receptor interaction on a cell-by-cell basis.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dimerization; Flow Cytometry; Humans; Models, Biological; Receptor, ErbB-2; Signal Transduction; Trastuzumab | 2008 |
Normal-like breast cells, but not breast cancer cells, recovered from treatment with N',N''-diethylnorspermine.
Topics: Antineoplastic Agents; Blotting, Western; Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Line; Cell Line, Tumor; Cyclin A; Cyclin A2; Cyclin B; Cyclin B1; Cyclin E; DNA; Epithelial Cells; Female; Flow Cytometry; Humans; Oncogene Proteins; Spermine | 2009 |
Suppression of ABCG2 inhibits cancer cell proliferation.
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Blotting, Western; Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Division; DNA Primers; Drug Resistance, Multiple; Female; Gene Silencing; Humans; Neoplasm Proteins; RNA Interference; RNA, Small Interfering; S Phase | 2010 |
A peptide fragment of azurin induces a p53-mediated cell cycle arrest in human breast cancer cells.
Topics: Animals; Azurin; Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cyclins; Female; Humans; Mice; Peptide Fragments; Proteasome Endopeptidase Complex; Protein Binding; Protein Processing, Post-Translational; Protein Stability; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2009 |
Human breast tumor slices: a model for identification of vitamin D regulated genes in the tumor microenvironment.
Topics: Aged; Breast Neoplasms; Bromodeoxyuridine; DNA, Complementary; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Humans; Middle Aged; Models, Biological; Oligonucleotide Array Sequence Analysis; RNA, Messenger; Steroid Hydroxylases; Time Factors; Vitamin D; Vitamin D3 24-Hydroxylase | 2010 |
Comparison of combinatory effects of PCBs (118, 138, 153 and 180) with 17 beta-estradiol on proliferation and apoptosis in MCF-7 breast cancer cells.
Topics: Apoptosis; Breast Neoplasms; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Interactions; Estradiol; Female; Humans; Polychlorinated Biphenyls | 2011 |
An integrative approach to identify YB-1-interacting proteins required for cisplatin resistance in MCF7 and MDA-MB-231 breast cancer cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Bromodeoxyuridine; Cell Line, Tumor; Cisplatin; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Resistance; Female; Humans; Nuclear Proteins; Ribosomal Proteins; RNA, Small Interfering; Y-Box-Binding Protein 1 | 2011 |
Scorpion (Androctonus crassicauda) venom limits growth of transformed cells (SH-SY5Y and MCF-7) by cytotoxicity and cell cycle arrest.
Topics: Animals; Apoptosis; Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Line, Transformed; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Fragmentation; DNA Replication; Female; Formazans; Humans; Lactate Dehydrogenases; Membrane Potential, Mitochondrial; Neuroblastoma; Nitric Oxide; Scorpion Venoms; Tetrazolium Salts; Tumor Stem Cell Assay | 2011 |
Lack of angiogenesis in experimental brain metastases.
Topics: Angiopoietin-1; Animals; Brain Neoplasms; Breast Neoplasms; Bromodeoxyuridine; Carcinoma; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Disease Models, Animal; DNA-Binding Proteins; Electron Microscope Tomography; Female; Glial Fibrillary Acidic Protein; Humans; Keratins; Lamins; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Quinolines; Receptor, Platelet-Derived Growth Factor beta; Thiazoles; Vascular Endothelial Growth Factor A | 2011 |
Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors.
Topics: Adult; Aged; Animals; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Bromodeoxyuridine; Carcinoma, Ductal, Breast; Cell Line, Tumor; Endogenous Retroviruses; Enzyme-Linked Immunosorbent Assay; Feasibility Studies; Female; Flow Cytometry; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Viral; Gene Products, env; Humans; Immunoblotting; Immunohistochemistry; Immunotherapy; In Situ Nick-End Labeling; Ki-67 Antigen; Mice; Mice, Nude; Middle Aged; Molecular Targeted Therapy; Neoplasm Grading; Neoplasm Staging; Pilot Projects; Protein Array Analysis; Random Allocation; Retroviridae Proteins; Signal Transduction; Transplantation, Heterologous; Tumor Suppressor Protein p53; Up-Regulation | 2012 |
Impaired cognitive function and hippocampal neurogenesis following cancer chemotherapy.
Topics: Analysis of Variance; Animals; Antineoplastic Agents; Body Weight; Breast Neoplasms; Bromodeoxyuridine; Cognition Disorders; Conditioning, Psychological; Cyclophosphamide; Doxorubicin; Fear; Female; Fluorescent Antibody Technique; Hippocampus; Humans; Learning; Male; Memory; Motor Activity; Neurogenesis; Neurons; Rats; Rats, Nude | 2012 |
Characterization of pyrimidine nucleoside phosphorylase of Mycoplasma hyorhinis: implications for the clinical efficacy of nucleoside analogues.
Topics: Amino Acid Sequence; Antiviral Agents; Breast Neoplasms; Bromodeoxyuridine; Computational Biology; Female; Humans; Idoxuridine; Kinetics; Molecular Sequence Data; Mycoplasma hyorhinis; Mycoplasma Infections; Protein Conformation; Pyrimidine Nucleosides; Sequence Homology, Amino Acid; Substrate Specificity; Thymidine Phosphorylase; Tumor Cells, Cultured; Uridine Phosphorylase; Viruses | 2012 |
Potent anticancer effects of lentivirus encoding a Drosophila melanogaster deoxyribonucleoside kinase mutant combined with brivudine.
Topics: Amino Acid Sequence; Animals; Antiviral Agents; Apoptosis; Blotting, Western; Breast Neoplasms; Bromodeoxyuridine; Cell Proliferation; Colorectal Neoplasms; Combined Modality Therapy; Drosophila melanogaster; Female; Flow Cytometry; Genetic Therapy; Genetic Vectors; Humans; Lentivirus; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutant Proteins; Mutation; Phosphotransferases (Alcohol Group Acceptor); Prohibitins; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sequence Homology, Amino Acid; Stomach Neoplasms; Tumor Cells, Cultured | 2012 |
Tart cherry juice induces differential dose-dependent effects on apoptosis, but not cellular proliferation, in MCF-7 human breast cancer cells.
Topics: Anthocyanins; Apoptosis; Beverages; Breast Neoplasms; Bromodeoxyuridine; Cell Division; Cell Proliferation; Dose-Response Relationship, Drug; Female; Fruit; Humans; L-Lactate Dehydrogenase; MCF-7 Cells; Mitochondria; Necrosis; Phytotherapy; Plant Extracts; Polyphenols; Prunus | 2012 |
Cytotoxic effects of adenovirus- and lentivirus-mediated expression of Drosophila melanogaster deoxyribonucleoside kinase on Bcap37 breast cancer cells.
Topics: Adenoviridae; Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Cell Survival; Combined Modality Therapy; Drosophila Proteins; Female; Gene Expression; Genetic Therapy; Genetic Vectors; HEK293 Cells; Humans; Lentivirus; Mice; Mice, Inbred BALB C; Mice, Nude; Phosphotransferases (Alcohol Group Acceptor); Prodrugs; Prohibitins; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
G(1)/S but not G(0)/G(1)cell fraction is related to 5-fluorouracil cytotoxicity.
Topics: Adenocarcinoma; Antimetabolites; Antimetabolites, Antineoplastic; Breast Neoplasms; Bromodeoxyuridine; Coloring Agents; Female; Flow Cytometry; Fluorouracil; G1 Phase; Head and Neck Neoplasms; Humans; Pancreatic Neoplasms; Propidium; Resting Phase, Cell Cycle; S Phase; Tumor Cells, Cultured | 2002 |
Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts.
Topics: Animals; Basement Membrane; Breast Neoplasms; Bromodeoxyuridine; Cadherins; Cell Adhesion; Cell Death; Cell Division; Colony-Forming Units Assay; Enzyme Inhibitors; ErbB Receptors; Female; Humans; Integrin beta1; Mice; Mice, Inbred BALB C; Mice, Nude; Mitogen-Activated Protein Kinases; Monomeric GTP-Binding Proteins; Neoplasm Invasiveness; Neoplasms, Experimental; Phenotype; Phosphatidylinositol 3-Kinases; Protein-Tyrosine Kinases; Signal Transduction; Tumor Cells, Cultured; Vimentin | 2002 |
Increased proteasome-dependent degradation of estrogen receptor-alpha by TGF-beta1 in breast cancer cell lines.
Topics: Blotting, Northern; Blotting, Western; Breast Neoplasms; Bromodeoxyuridine; Cell Division; Cysteine Endopeptidases; Estradiol; Estrogen Receptor alpha; Flow Cytometry; Humans; Leupeptins; Multienzyme Complexes; Proteasome Endopeptidase Complex; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Cells, Cultured; Ubiquitin | 2003 |
Inhibition of cell growth by NB1011 requires high thymidylate synthase levels and correlates with p53, p21, bax, and GADD45 induction.
Topics: Animals; Annexin A5; Antimetabolites, Antineoplastic; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Division; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Epithelial Cells; Female; Fibroblasts; GADD45 Proteins; Humans; Intracellular Signaling Peptides and Proteins; Mice; Mice, Nude; Oncogene Protein p21(ras); Protein Biosynthesis; Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; Thymidylate Synthase; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2002 |
Induction of apoptosis in estrogen dependent and independent breast cancer cells by the marine terpenoid dehydrothyrsiferol.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Bromodeoxyuridine; Camptothecin; Cell Cycle; Cell Division; Colchicine; DNA; Doxorubicin; Estrogens; Humans; Phosphatidylserines; Pyrans; Tumor Cells, Cultured | 2003 |
NB1011 induces Ser15 phosphorylation of p53 and activates the G2/M checkpoint.
Topics: Adenocarcinoma; Breast Neoplasms; Bromodeoxyuridine; Colonic Neoplasms; Humans; Phosphorylation; Thymidylate Synthase; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2003 |
Mature adipocytes, but not preadipocytes, promote the growth of breast carcinoma cells in collagen gel matrix culture through cancer-stromal cell interactions.
Topics: Adipocytes; Analysis of Variance; Animals; Apoptosis; Biomarkers; Breast; Breast Neoplasms; Bromodeoxyuridine; Cadherins; Cell Adhesion; Cell Communication; Cell Differentiation; Coculture Techniques; Collagen; Estrogen Receptor beta; Female; Gels; Humans; Rats; Receptors, Estrogen; Stromal Cells; Tumor Cells, Cultured | 2003 |
Exposure to continuous bromodeoxyuridine (BrdU) differentially affects cell cycle progression of human breast and bladder cancer cell lines.
Topics: Apoptosis; Breast Neoplasms; Bromodeoxyuridine; Carcinoma; Cell Cycle; Cell Line, Tumor; Cell Survival; Cytogenetic Analysis; DNA; DNA Replication; Dose-Response Relationship, Drug; Female; Flow Cytometry; Humans; Male; Prostatic Neoplasms; Reproducibility of Results | 2004 |
Overexpression of HER2 (erbB2) in human breast epithelial cells unmasks transforming growth factor beta-induced cell motility.
Topics: Actins; Activin Receptors, Type I; Adenoviridae; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Blotting, Northern; Breast Neoplasms; Bromodeoxyuridine; Butadienes; Cell Cycle; Cell Division; Cell Line; Cell Line, Tumor; Cell Movement; Chromones; Disease Progression; DNA, Complementary; Enzyme Inhibitors; Epithelial Cells; Gene Expression Regulation; Genes, Reporter; Green Fluorescent Proteins; Humans; Imidazoles; Immunoblotting; Integrin beta1; Ligands; Luminescent Proteins; Microscopy, Fluorescence; Models, Genetic; Morpholines; Nitriles; Phosphoinositide-3 Kinase Inhibitors; Precipitin Tests; Protein Serine-Threonine Kinases; Pseudopodia; Pyridines; rac1 GTP-Binding Protein; Receptor, ErbB-2; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Retroviridae; Signal Transduction; Transcription, Genetic; Transforming Growth Factor beta; Trastuzumab; Wound Healing | 2004 |
Deregulation of cell proliferation by polycyclic aromatic hydrocarbons in human breast carcinoma MCF-7 cells reflects both genotoxic and nongenotoxic events.
Topics: Benz(a)Anthracenes; Benzo(a)pyrene; Benzothiazoles; Breast Neoplasms; Bromodeoxyuridine; Carcinogens; Carcinoma; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Replication; Dose-Response Relationship, Drug; Drug Interactions; Epigenesis, Genetic; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Receptors, Estrogen; Thiazoles; Toluene; Tumor Suppressor Protein p53 | 2005 |
A Markov model approach shows a large variation in the length of S phase in MCF-7 breast cancer cells.
Topics: Analysis of Variance; Breast Neoplasms; Bromodeoxyuridine; Cell Line, Tumor; DNA; Flow Cytometry; Humans; Markov Chains; Regression Analysis; Replicon; S Phase; Time Factors | 2005 |
Breast carcinoma malignancy grading by Bloom-Richardson system vs proliferation index: reproducibility of grade and advantages of proliferation index.
Topics: Breast Neoplasms; Bromodeoxyuridine; Cell Nucleus; Cell Proliferation; DNA, Neoplasm; Female; Humans; Mitotic Index; Pathology, Clinical; Reproducibility of Results; Severity of Illness Index; Survival Analysis; Thymidine; Tritium | 2005 |
Estrogen negatively regulates epidermal growth factor (EGF)-mediated signal transducer and activator of transcription 5 signaling in human EGF family receptor-overexpressing breast cancer cells.
Topics: Breast Neoplasms; Bromodeoxyuridine; Enzyme Activation; Epidermal Growth Factor; ErbB Receptors; Estradiol; Estrogen Receptor alpha; Genes, Reporter; Humans; Luciferases; Mitogen-Activated Protein Kinase Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; src-Family Kinases; STAT5 Transcription Factor; Transcription, Genetic; Transfection; Tumor Cells, Cultured | 2005 |
Inhibition of estradiol-induced mammary proliferation by dibenzoylmethane through the E2-ER-ERE-dependent pathway.
Topics: Animals; Breast Neoplasms; Bromodeoxyuridine; Cell Proliferation; Chalcones; Chromatin Immunoprecipitation; Diet; Estradiol; Estrogen Antagonists; Female; Genes, ras; Humans; Injections, Intraperitoneal; Mammary Glands, Animal; Mice; Mice, Inbred SENCAR; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Receptors, Estrogen; Response Elements; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Telomerase; Tumor Cells, Cultured | 2006 |
Transactivating agonists of the EGF receptor require Tyr 845 phosphorylation for induction of DNA synthesis.
Topics: Animals; Blotting, Western; Breast Neoplasms; Bromodeoxyuridine; Cells, Cultured; Chickens; DNA; Endothelins; ErbB Receptors; Fibroblasts; Growth Hormone; Humans; Immunoprecipitation; Lysophospholipids; Mice; Mice, Inbred C3H; Peptide Fragments; Phosphorylation; Proto-Oncogene Proteins pp60(c-src); S Phase; STAT5 Transcription Factor; Trans-Activators; Tyrosine | 2005 |
Effect of the selective estrogen receptor modulator arzoxifene on repopulation of hormone-responsive breast cancer xenografts between courses of chemotherapy.
Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Female; Humans; Immunohistochemistry; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Piperidines; Receptors, Estrogen; Thiophenes; Treatment Outcome; Xenograft Model Antitumor Assays | 2005 |
Prohibitin is a novel target gene of vitamin D involved in its antiproliferative action in breast cancer cells.
Topics: Base Sequence; Breast Neoplasms; Bromodeoxyuridine; Cell Line, Tumor; Cell Nucleus; Humans; Hydroxycholecalciferols; Molecular Sequence Data; Prohibitins; Promoter Regions, Genetic; Repressor Proteins; RNA Interference; S Phase; Steroid Hydroxylases; Transcription, Genetic; Transcriptional Activation; Vitamin D3 24-Hydroxylase | 2006 |
Ki-67 correlates with in vivo bromodeoxyuridine labeling index in operable breast cancer.
Topics: Antimetabolites, Antineoplastic; Biomarkers, Tumor; Breast Neoplasms; Bromodeoxyuridine; Female; Humans; Ki-67 Antigen; S Phase | 2006 |
Effect of c-neu/ ErbB2 expression levels on estrogen receptor alpha-dependent proliferation in mammary epithelial cells: implications for breast cancer biology.
Topics: Animals; Breast; Breast Neoplasms; Bromodeoxyuridine; Cell Proliferation; Epithelial Cells; Estrogen Receptor alpha; Mice; Mice, Transgenic; Receptor, ErbB-2 | 2006 |
MEK ablation in MCF-7 cells blocks DNA synthesis induced by serum, but not by estradiol or growth factors.
Topics: Breast Neoplasms; Bromodeoxyuridine; Culture Media, Serum-Free; DNA, Neoplasm; Estradiol; Fibroblast Growth Factor 1; Humans; Insulin-Like Growth Factor I; Intercellular Signaling Peptides and Proteins; MAP Kinase Kinase 1; MAP Kinase Kinase 2; MAP Kinase Kinase Kinases; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neuregulin-1; Nucleic Acid Synthesis Inhibitors; Phosphorylation; RNA, Small Interfering; Serum; Transfection | 2006 |
The influence of lycopene on the proliferation of human breast cell line (MCF-7).
Topics: Anticarcinogenic Agents; Breast Neoplasms; Bromodeoxyuridine; Carotenoids; Cell Communication; Cell Line, Tumor; Cell Proliferation; Connexin 43; Female; Gap Junctions; Humans; Immunohistochemistry; Lycopene; RNA, Messenger | 2007 |
Synergistic apoptosis of MCF-7 breast cancer cells by 2-methoxyestradiol and bis(ethyl)norspermine.
Topics: 2-Methoxyestradiol; Apoptosis; Blotting, Western; Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Line, Tumor; Cell Nucleus; Cyclin D1; Drug Synergism; Estradiol; Humans; Microscopy, Confocal; Phosphorylation; Proto-Oncogene Proteins c-akt; Spermine | 2007 |
[Growth inhibition and multidrug resistance-reversing effect of tanshinone I A on human breast cancer cell with estrogen receptor negative].
Topics: Abietanes; Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Phenanthrenes; Receptors, Estrogen | 2007 |
Differential impact of Cetuximab, Pertuzumab and Trastuzumab on BT474 and SK-BR-3 breast cancer cell proliferation.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzimidazoles; Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cetuximab; ErbB Receptors; Fluorescent Dyes; Humans; Ki-67 Antigen; RNA Interference; S Phase; Trastuzumab | 2007 |
Epidermal growth factor receptor pathway analysis identifies amphiregulin as a key factor for cisplatin resistance of human breast cancer cells.
Topics: Amphiregulin; Antineoplastic Agents; Breast Neoplasms; Bromodeoxyuridine; Cell Division; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; EGF Family of Proteins; Enzyme-Linked Immunosorbent Assay; ErbB Receptors; Female; Glycoproteins; Humans; Intercellular Signaling Peptides and Proteins; Neoplasm Invasiveness; Phosphorylation; Protein Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction | 2008 |
NF-kappaB downregulation may be involved the depression of tumor cell proliferation mediated by human mesenchymal stem cells.
Topics: Breast Neoplasms; Bromodeoxyuridine; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Culture Media, Conditioned; Down-Regulation; Female; Fetus; Flow Cytometry; Genes, Reporter; Humans; Liver Neoplasms; Luciferases; Mesenchymal Stem Cells; NF-kappa B; Plasmids; Time Factors | 2008 |
Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Bromodeoxyuridine; CD24 Antigen; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Female; Flow Cytometry; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Hyaluronan Receptors; Membrane Proteins; Mice; Mice, Inbred NOD; Mice, SCID; Neoplastic Stem Cells; Paclitaxel; Phenotype | 2008 |
Different cell cycle kinetic effects of N1,N11-diethylnorspermine-induced polyamine depletion in four human breast cancer cell lines.
Topics: Antineoplastic Agents; Blotting, Western; Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Line, Tumor; Cell Survival; Cyclins; Female; Flow Cytometry; Humans; Microscopy, Fluorescence; Polyamines; Spermine | 2008 |
Cytotoxic effects of butanolic extract from Pfaffia paniculata (Brazilian ginseng) on cultured human breast cancer cell line MCF-7.
Topics: Amaranthaceae; Breast Neoplasms; Bromodeoxyuridine; Butanols; Cell Line, Tumor; Cell Proliferation; Female; Humans; Immunohistochemistry; Microscopy, Electron, Transmission; Phytotherapy; Plant Extracts; Plant Roots | 2009 |
Identification of bromodeoxyuridine in malignant and normal cells following therapy: relationship to complications.
Topics: Bone Marrow; Breast Neoplasms; Bromodeoxyuridine; Combined Modality Therapy; Female; Humans; Melanoma; Neoplasms; Photosensitivity Disorders; Radiation-Sensitizing Agents; Skin | 1984 |
Chromosomal replication asynchrony of a human breast carcinoma cell line. I. studied by continuous BrdU incorporation and G-banding analysis.
Topics: Azure Stains; Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Line; Chromosome Banding; Chromosome Mapping; Chromosomes; DNA Replication; Female; Humans; Karyotyping | 1982 |
Variant T47D human breast cancer cells with high progesterone-receptor levels despite estrogen and antiestrogen resistance.
Topics: Breast Neoplasms; Bromodeoxyuridine; Butyrates; Cell Nucleus; Cells, Cultured; Cycloheximide; Cytoplasm; Estradiol; Female; Humans; Nafoxidine; Promegestone; Receptors, Estrogen; Receptors, Progesterone | 1982 |
5-Bromodeoxyuridine specifically inhibits the synthesis of estrogen-induced proteins in MCF7 cells.
Topics: Breast Neoplasms; Bromodeoxyuridine; Cell Division; Cell Line; DNA Replication; Dose-Response Relationship, Drug; Estradiol; Female; Humans; Kinetics; Neoplasm Proteins; Receptors, Progesterone | 1981 |
Nuclear translocation and interactions of the estrogen receptor in uterus and mammary tumors.
Topics: Animals; Biological Transport; Breast Neoplasms; Bromodeoxyuridine; Castration; Cell Nucleus; Chromatin; Cytosol; DNA; Female; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Micrococcal Nuclease; Rats; Receptors, Estrogen; Uterus | 1980 |
Role of tumor-derived fibroblasts in the growth of primary cultures of human breast-cancer cells: effects of epidermal growth factor and the somatostatin analogue octreotide.
Topics: Adult; Aged; Breast Neoplasms; Bromodeoxyuridine; Cell Communication; Cell Division; Epidermal Growth Factor; Epithelial Cells; Epithelium; Fibroblasts; Humans; Keratins; Middle Aged; Octreotide; Thymidine; Tritium; Tumor Cells, Cultured | 1995 |
Tumour kinetics in breast cancer.
Topics: Breast Neoplasms; Bromodeoxyuridine; Cell Division; DNA, Neoplasm; Female; Flow Cytometry; Humans; Kinetics; Middle Aged; Mitotic Index; Prospective Studies; Receptors, Estrogen | 1994 |
Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer.
Topics: Adult; Aged; Antigens, Differentiation, Myelomonocytic; Breast Neoplasms; Bromodeoxyuridine; Cell Division; Endothelium, Vascular; Female; Humans; Middle Aged; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1 | 1993 |
Cell proliferation in hyperplastic and in situ carcinoma lesions of the breast estimated by in vivo labeling with bromodeoxyuridine.
Topics: Adult; Aged; Breast; Breast Neoplasms; Bromodeoxyuridine; Carcinoma in Situ; Carcinoma, Ductal, Breast; Cell Division; Female; Humans; Hyperplasia; Immunohistochemistry; Middle Aged; Neoplasm Invasiveness; Reference Values | 1994 |
Cell cycle kinetic effects of tamoxifen on human breast cancer cells. Flow cytometric analyses of DNA content, BrdU labeling, Ki-67, PCNA, and statin expression.
Topics: Biomarkers, Tumor; Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Cycle Proteins; Cell Line; DNA, Neoplasm; Female; Flow Cytometry; Fluorescent Antibody Technique; Humans; Immunohistochemistry; Ki-67 Antigen; Kinetics; Neoplasm Proteins; Nuclear Proteins; Peptide Elongation Factor 1; Proliferating Cell Nuclear Antigen; Protein Biosynthesis; Proteins; Tamoxifen; Tumor Cells, Cultured | 1993 |
Assessment of proliferating cell nuclear antigen (PCNA) in breast cancer using anti-PCNA PC10 and 19A2: correlation with 5-bromo-2'-deoxyuridine or tritiated thymidine labeling and flow cytometric analysis.
Topics: Antibodies, Monoclonal; Breast Neoplasms; Bromodeoxyuridine; Cell Division; Flow Cytometry; Formaldehyde; Humans; Immunohistochemistry; Isotope Labeling; Proliferating Cell Nuclear Antigen; Retrospective Studies; Thymidine; Tissue Fixation; Tritium | 1994 |
High proliferative rates demonstrated by bromodeoxyuridine labeling index in breast carcinomas with p53 overexpression.
Topics: Breast Neoplasms; Bromodeoxyuridine; Carcinoma; Cell Division; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Genes, p53; Humans; Immunoenzyme Techniques; Receptors, Estrogen; Receptors, Progesterone; Tumor Suppressor Protein p53 | 1994 |
Cell cycle-dependent expression of estrogen receptor and effect of estrogen on proliferation of synchronized human osteoblast-like osteosarcoma cells.
Topics: Animals; Blotting, Northern; Blotting, Western; Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Division; Cell Nucleus; DNA; Estradiol; Fluoroimmunoassay; Gene Expression; Humans; Mice; Osteoblasts; Osteosarcoma; Receptors, Estrogen; RNA, Messenger; Tumor Cells, Cultured | 1994 |
In vitro bromodeoxyuridine labeling of malignant neoplasms. A comparative study with flow cytometry cell-cycle analysis.
Topics: Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Flow Cytometry; Humans; Immunohistochemistry; Lung Neoplasms; Neoplasms | 1994 |
Cell proliferation of breast cancer evaluated by anti-BrdU and anti-Ki-67 antibodies: its prognostic value on short-term recurrences.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Bromodeoxyuridine; Cell Division; DNA, Neoplasm; Female; Humans; Ki-67 Antigen; Lymph Nodes; Middle Aged; Neoplasm Proteins; Neoplasm Recurrence, Local; Nuclear Proteins; Prognosis | 1993 |
Correlation of bromodeoxyuridine (BRDU) labeling of breast carcinoma cells with mitotic figure content and tumor grade.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Bromodeoxyuridine; Carcinoma; Cell Division; Female; Humans; Middle Aged; Mitotic Index; Prognosis | 1993 |
Influences on measurement of cellular proliferation by histology and flow cytometry in mammary carcinomas labeled in vivo with bromodeoxyuridine.
Topics: Breast Neoplasms; Bromodeoxyuridine; Carcinoma; Cell Count; Cell Division; Female; Flow Cytometry; Humans; Immunohistochemistry; Ploidies | 1993 |
Bromodeoxyuridine labeling for S-phase measurement in breast carcinoma.
Topics: Breast Neoplasms; Bromodeoxyuridine; Carcinoma; Cryopreservation; Female; Humans; In Vitro Techniques; S Phase; Thymidine | 1993 |
Tumor labeling indices of primary breast cancers and their regional lymph node metastases.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Bromodeoxyuridine; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Regression Analysis | 1993 |
Identification of resting cells by dual-parameter flow cytometry of statin expression and DNA content.
Topics: 3T3 Cells; Animals; Antigens, Neoplasm; Apoptosis; Biomarkers; Breast Neoplasms; Bromodeoxyuridine; Cell Cycle Proteins; Cell Division; Cell Line, Transformed; DNA, Neoplasm; Estrogen Antagonists; Estrogens; Female; Fixatives; Flow Cytometry; Fluorescent Antibody Technique; Formaldehyde; Gene Expression; Glioma; Humans; Ki-67 Antigen; Mice; Neoplasm Proteins; Nuclear Proteins; Polymers; Proliferating Cell Nuclear Antigen; Propidium; Proteins; Rats; Resting Phase, Cell Cycle; Tamoxifen; Thymus Gland | 1995 |
Cell kinetics in vivo of human breast cancer.
Topics: Breast Neoplasms; Bromodeoxyuridine; Cell Division; Female; Flow Cytometry; Genes, erbB-2; Humans; Immunohistochemistry; Ploidies; S Phase | 1996 |
Proliferative activity in breast carcinoma evaluated by BrdU and PCNA. Correlation with expression of p53, c-erbB-2, estrogen receptor and P-glycoprotein.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Bromodeoxyuridine; Case-Control Studies; Cell Division; Evaluation Studies as Topic; Female; Humans; Middle Aged; Neoplasm Proteins; Proliferating Cell Nuclear Antigen; Receptor, ErbB-2; Receptors, Estrogen; Tumor Suppressor Protein p53 | 1995 |
Histological grade in invasive ductal carcinoma of breast correlates with the proliferative activity evaluated by BrdU: an immunohistochemical study including correlations with p53, c-erbB-2 and estrogen receptor status.
Topics: Adult; Aged; Breast Neoplasms; Bromodeoxyuridine; Carcinoma, Ductal, Breast; Cell Division; Evaluation Studies as Topic; Female; Humans; Immunohistochemistry; Middle Aged; Neoplasm Invasiveness; Neoplasm Proteins; Receptor, ErbB-2; Receptors, Estrogen; Tumor Suppressor Protein p53 | 1996 |
Fluorescein-labeled tyramide strongly enhances the detection of low bromodeoxyuridine incorporation levels.
Topics: Breast Neoplasms; Bromodeoxyuridine; Female; Fluorescein; Fluoresceins; Humans; Immunohistochemistry; S Phase; Tumor Cells, Cultured; Tyramine | 1997 |
Comparison of mathematical formulas used for estimation of DNA synthesis time of bromodeoxyuridine-labelled cell populations with different proliferative characteristics.
Topics: Adenocarcinoma; Animals; Breast Neoplasms; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cells, Cultured; DNA; Endometrial Neoplasms; Female; Fibroblasts; Flow Cytometry; Head and Neck Neoplasms; Humans; In Vitro Techniques; Kinetics; Lung; Mathematical Computing; Mice; Mice, Inbred BALB C; Mice, Nude; Sampling Studies; Time Factors; Tissue Transplantation; Tumor Cells, Cultured | 1996 |
Proliferation marker MIB-1 correlates well with proliferative activity evaluated by BrdU in breast cancer: an immunohistochemical study including correlation with PCNA, p53, c-erbB-2 and estrogen receptor status.
Topics: Adult; Aged; Antigens, Nuclear; Biomarkers, Tumor; Breast Neoplasms; Bromodeoxyuridine; Carcinoma, Ductal, Breast; Cell Division; DNA; DNA Replication; Female; Humans; Immunohistochemistry; Ki-67 Antigen; Middle Aged; Nuclear Proteins; Proliferating Cell Nuclear Antigen; Receptor, ErbB-2; Receptors, Estrogen; Tumor Suppressor Protein p53 | 1996 |
[Determination of the proliferative activity of breast cancer cells using 5-bromo-2'-deoxyuridine in vivo].
Topics: Antimetabolites, Antineoplastic; Breast Neoplasms; Bromodeoxyuridine; Cell Division; Female; Humans; Immunohistochemistry; In Vitro Techniques | 1997 |
Potential of Varicella zoster virus thymidine kinase as a suicide gene in breast cancer cells.
Topics: 3T3 Cells; Animals; Antiviral Agents; Breast Neoplasms; Bromodeoxyuridine; Combined Modality Therapy; Female; Genetic Therapy; Genetic Vectors; Herpesvirus 3, Human; Humans; Mice; Mice, Nude; Rats; Thymidine Kinase; Tumor Cells, Cultured | 1997 |
Genetic alterations in lobular breast cancer by comparative genomic hybridization.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Bromodeoxyuridine; Cadherins; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chromosome Aberrations; DNA, Neoplasm; Female; Humans; Immunohistochemistry; Middle Aged; Nucleic Acid Hybridization | 1997 |
Activated cell cycle checkpoints in epirubicin-treated breast cancer cells studied by BrdUrd-flow cytometry.
Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Epirubicin; Female; Flow Cytometry; Genes, p53; Humans; RNA, Messenger; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1997 |
Preparation, characterization and in vitro efficacy of albumin conjugates of doxorubicin.
Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Bromodeoxyuridine; Chromatography, High Pressure Liquid; Doxorubicin; Female; Humans; Hydrogen-Ion Concentration; Leukemia, Experimental; Maleimides; Serum Albumin; Spectrophotometry, Ultraviolet; Thymidine; Tumor Cells, Cultured | 1998 |
A simple method of tumour culture.
Topics: Adenocarcinoma; Breast Neoplasms; Bromodeoxyuridine; Cell Division; Colorectal Neoplasms; Culture Techniques; Female; Humans; Stromal Cells; Tumor Cells, Cultured | 1998 |
Bcl-2 slows in vitro breast cancer growth despite its antiapoptotic effect.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antimetabolites; Apoptosis; Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Doxorubicin; Gene Expression Regulation, Neoplastic; Humans; Proto-Oncogene Proteins c-bcl-2; Transfection; Tumor Cells, Cultured | 1998 |
The functional relationship between in vivo bromodeoxyuridine labeling index and Ki-67 proliferation index in human breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Bromodeoxyuridine; Female; Humans; Ki-67 Antigen; Male; Middle Aged; Mitotic Index; Prognosis; Risk Factors | 1998 |
Comparison of flow and laser scanning cytometry for the assay of cell proliferation in human solid tumors.
Topics: Adenocarcinoma; Breast Neoplasms; Bromodeoxyuridine; Carcinoma, Ductal, Breast; DNA; Female; Flow Cytometry; Humans; Image Cytometry; Metaplasia; Stomach Neoplasms | 1998 |
Tumor growth of FGF or VEGF transfected MCF-7 breast carcinoma cells correlates with density of specific microvessels independent of the transfected angiogenic factor.
Topics: Animals; Breast Neoplasms; Bromodeoxyuridine; Carcinoma; Disease Models, Animal; Endothelial Growth Factors; Estradiol; Female; Fibroblast Growth Factors; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Inflammation; Lymphokines; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Microcirculation; Neoplasm Transplantation; Neovascularization, Pathologic; Ovariectomy; Prognosis; Tamoxifen; Transfection; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1998 |
Comparison of mitotic index, in vitro bromodeoxyuridine labeling, and MIB-1 assays to quantitate proliferation in breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Bromodeoxyuridine; Cell Division; Female; Humans; Immunohistochemistry; Ki-67 Antigen; Middle Aged; Mitotic Index; Multivariate Analysis; Predictive Value of Tests; Prognosis | 1999 |
Overexpression of c-Myc inhibits p21WAF1/CIP1 expression and induces S-phase entry in 12-O-tetradecanoylphorbol-13-acetate (TPA)-sensitive human cancer cells.
Topics: Adenoviridae; Apoptosis; Blotting, Western; Breast Neoplasms; Bromodeoxyuridine; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Kinetics; Luciferases; Male; Prostatic Neoplasms; Proto-Oncogene Proteins c-myc; S Phase; Tetradecanoylphorbol Acetate; Thymidine; Time Factors; Transcription, Genetic; Transfection; Tumor Cells, Cultured | 1999 |
[Immunohistochemical evaluation of the in vitro bromodeoxyuridine labeling index. 236 breast cancers studies by image analysis].
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Bromodeoxyuridine; DNA, Neoplasm; Female; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Linear Models; Middle Aged; Prognosis; S Phase | 1999 |
Analysis of oxidative DNA damage and HPRT mutant frequencies in cancer patients before and after radiotherapy.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Aged, 80 and over; Antioxidants; Biomarkers; Breast Neoplasms; Bromodeoxyuridine; Deoxyguanosine; DNA Damage; Female; Head and Neck Neoplasms; Humans; Hypoxanthine Phosphoribosyltransferase; Male; Micronucleus Tests; Middle Aged; Neoplasms; Oxidation-Reduction; Prostatic Neoplasms; Smoking | 1999 |
Energy transfer between fluorescein isothiocyanate and propidium iodide--a problem in the estimation of Tpot with the bromodeoxyuridine-DNA flow cytometry technique?
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Antimetabolites; Breast Neoplasms; Bromodeoxyuridine; CHO Cells; Coloring Agents; Cricetinae; DNA, Neoplasm; Energy Transfer; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; G1 Phase; G2 Phase; Humans; Propidium | 1999 |
Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and its arabinosyl derivative, (E)-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil (BVaraU), against tumor cells expressing either the Varicella zoster or
Topics: Animals; Antineoplastic Agents; Antiviral Agents; Arabinofuranosyluracil; Breast Neoplasms; Bromodeoxyuridine; Female; Genetic Vectors; Herpesvirus 3, Human; Humans; Male; Mice; Mice, Nude; Rats; Rats, Inbred F344; Simplexvirus; Thymidine Kinase; Tumor Cells, Cultured | 2000 |
The prognostic value of proliferation indices: a study with in vivo bromodeoxyuridine and Ki-67.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Humans; Immunohistochemistry; Ki-67 Antigen; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Radiation-Sensitizing Agents; Radiotherapy, Adjuvant | 2000 |
Serum withdrawal-induced post-transcriptional stabilization of cyclooxygenase-2 mRNA in MDA-MB-231 mammary carcinoma cells requires the activity of the p38 stress-activated protein kinase.
Topics: Apoptosis; Blotting, Northern; Blotting, Western; Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Nucleus; Culture Media, Serum-Free; Cyclooxygenase 2; Dactinomycin; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Genes, Dominant; Humans; Imidazoles; Isoenzymes; Membrane Proteins; Microscopy, Fluorescence; Mitogen-Activated Protein Kinases; Nucleic Acid Synthesis Inhibitors; p38 Mitogen-Activated Protein Kinases; Prostaglandin-Endoperoxide Synthases; Pyridines; RNA Processing, Post-Transcriptional; RNA, Messenger; Signal Transduction; Time Factors; Transfection; Tumor Cells, Cultured | 2000 |
Clinical outcome and bromodeoxyuridine-derived proliferation indices in 75 invasive breast carcinomas.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Female; Flow Cytometry; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Proportional Hazards Models; Survival Analysis | 2000 |
Signal transduction through the Ras/Erk pathway is essential for the mycoestrogen zearalenone-induced cell-cycle progression in MCF-7 cells.
Topics: Adenoviridae; Annexin A5; Blotting, Northern; Blotting, Western; Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Cycle Proteins; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p27; Down-Regulation; Estrogens, Non-Steroidal; Female; Flow Cytometry; Formazans; Genes, myc; Humans; Luciferases; Microtubule-Associated Proteins; Mitogen-Activated Protein Kinases; Mitosis; Phosphorylation; Proto-Oncogene Proteins p21(ras); Signal Transduction; Tetrazolium Salts; Tumor Cells, Cultured; Tumor Suppressor Proteins; Zearalenone | 2001 |
Early exposure of the rat mammary gland to estrogen and progesterone blocks co-localization of estrogen receptor expression and proliferation.
Topics: Animals; Breast Neoplasms; Bromodeoxyuridine; Carcinogens; Cell Division; Estradiol; Female; Fluorescent Antibody Technique; Mammary Glands, Animal; Methylnitrosourea; Progesterone; Rats; Rats, Inbred WF; Receptors, Estrogen | 2001 |
Nucleoside transport inhibitors, dipyridamole and p-nitrobenzylthioinosine, selectively potentiate the antitumor activity of NB1011.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Bromodeoxyuridine; Carrier Proteins; Cell Survival; Colonic Neoplasms; Dipyridamole; Drug Resistance, Neoplasm; Drug Synergism; Fluorouracil; Humans; Membrane Proteins; Nucleoside Transport Proteins; Quinazolines; Thioinosine; Thiophenes; Thymidylate Synthase; Tumor Cells, Cultured | 2002 |
Simultaneous assessment of TGFB and cell cycle kinetics using IUdR/BrdU infusions in human neoplasms from plastic-embedded tissue.
Topics: Antibodies, Monoclonal; Biopsy; Bone Marrow; Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Colonic Neoplasms; Female; Glioblastoma; Histological Techniques; Humans; Idoxuridine; Indicators and Reagents; Kinetics; Neoplasms; S Phase; Transforming Growth Factor beta | 1992 |
Measuring proliferation in routine fine needle aspirates. Immunocytochemical detection of bromodeoxyuridine incorporation and Ki-67 expression in breast aspirates.
Topics: Antibodies, Monoclonal; Biomarkers, Tumor; Biopsy, Needle; Breast Neoplasms; Bromodeoxyuridine; Cell Division; Female; Humans; Ki-67 Antigen; Nuclear Proteins; Prognosis; T-Lymphocytes | 1992 |
Mapping of intracellular halogenous molecules by low and high resolution SIMS microscopy.
Topics: Adrenal Cortex Hormones; Androgens; Breast Neoplasms; Bromocriptine; Bromodeoxyuridine; Cells, Cultured; Fluorometholone; Halogens; Humans; Mass Spectrometry; Microscopy; Mitosis; Nucleotides; Triamcinolone; Tumor Cells, Cultured | 1992 |
Measurement of bromodeoxyuridine labeling index, Ki-67 score and Ag-NOR count in breast carcinomas. Comparison with DNA ploidy.
Topics: Aged; Breast Neoplasms; Bromodeoxyuridine; Cell Division; Cell Nucleus; DNA, Neoplasm; Humans; Ki-67 Antigen; Middle Aged; Nuclear Proteins; Nucleolus Organizer Region; Ploidies; Silver Staining | 1992 |
Proliferation indices of invasive breast carcinomas after in vivo 5-bromo-2'-deoxyuridine labelling: a flow cytometric study of 75 tumours.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Bromodeoxyuridine; Female; Flow Cytometry; Humans; Lymph Nodes; Middle Aged; Mitotic Index | 1992 |
Cell-cycle-related staining patterns of anti-proliferating cell nuclear antigen monoclonal antibodies. Comparison with BrdUrd labeling and Ki-67 staining.
Topics: Antibodies, Monoclonal; Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Division; Female; Flow Cytometry; G1 Phase; Humans; Immunohistochemistry; Methotrexate; Nuclear Proteins; Ovarian Neoplasms; Proliferating Cell Nuclear Antigen; Resting Phase, Cell Cycle; S Phase; Tamoxifen | 1991 |
A comparison between bromodeoxyuridine and 3H thymidine labeling in human breast tumors.
Topics: Analysis of Variance; Autoradiography; Breast Neoplasms; Bromodeoxyuridine; Humans; Observer Variation; Staining and Labeling; Thymidine; Tritium | 1991 |
Loss of heterozygosity on chromosome 17p13 in breast carcinomas identifies tumors with high proliferation index.
Topics: Blotting, Southern; Breast Neoplasms; Bromodeoxyuridine; Cell Division; Cell Transformation, Neoplastic; Chromosomes, Human, Pair 17; DNA, Neoplasm; Heterozygote; Humans; Mitotic Index; Thymidine | 1992 |
Simultaneous analysis of chromosomal aneusomy and 5-bromodeoxyuridine incorporation in MCF-7 breast tumor cell line.
Topics: Aneuploidy; Breast Neoplasms; Bromodeoxyuridine; Cell Division; DNA Probes; DNA, Neoplasm; Humans; Nucleic Acid Hybridization; Tumor Cells, Cultured | 1991 |
Prolonged G2 phase of breast cancer cells and chromosome damage.
Topics: Adenocarcinoma; Breast Neoplasms; Bromodeoxyuridine; Chromosome Aberrations; Chromosome Banding; Chromosomes; Female; G2 Phase; Humans; Karyotyping; Time Factors; Tumor Cells, Cultured | 1991 |
How should bromodeoxyuridine labeling be counted?
Topics: Breast Neoplasms; Bromodeoxyuridine; Humans; Reagent Kits, Diagnostic | 1991 |
Breast cancer proliferation measured on cytological samples: a study by flow cytometry of S-phase fractions and BrdU incorporation.
Topics: Biopsy, Needle; Breast Neoplasms; Bromodeoxyuridine; Cell Division; DNA, Neoplasm; Female; Flow Cytometry; Humans; Mitotic Index; Ploidies; S Phase | 1991 |
In vivo measurement of breast cancer growth rate.
Topics: Breast Neoplasms; Bromodeoxyuridine; Cell Count; DNA, Neoplasm; Female; Humans; Interphase; Receptors, Estrogen; Receptors, Progesterone | 1991 |
Automatic classification of cells in cell cycle phases based on Ki-67 antigen quantification by fluorescence microscopy.
Topics: Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Data Interpretation, Statistical; Discriminant Analysis; Humans; Image Processing, Computer-Assisted; Ki-67 Antigen; Microscopy, Fluorescence; Nuclear Proteins; Tumor Cells, Cultured | 1991 |
Interphase cytogenetics of a male breast cancer.
Topics: Adult; Breast Neoplasms; Bromodeoxyuridine; Chromosome Aberrations; DNA Probes; DNA, Neoplasm; Flow Cytometry; Fluorescent Antibody Technique; Humans; Interphase; Male; Nucleic Acid Hybridization | 1991 |
Image cytometry of progesterone receptor expression during the cell cycle in the MCF-7 cell line.
Topics: Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; DNA, Neoplasm; Flow Cytometry; Fluorescent Antibody Technique; Humans; Image Processing, Computer-Assisted; Microscopy, Fluorescence; Receptors, Progesterone; Tumor Cells, Cultured | 1991 |
AgNOR area in interphase nuclei of human tumours correlates with the proliferative activity evaluated by bromodeoxyuridine labelling and Ki-67 immunostaining.
Topics: Breast Neoplasms; Bromodeoxyuridine; Colonic Neoplasms; Goiter, Nodular; Humans; Interphase; Liver Neoplasms; Mitosis; Neoplasms; Nuclear Proteins; Nucleolus Organizer Region; Thyroid Neoplasms | 1991 |
Evaluation of in vitro bromodeoxyuridine labeling of breast carcinomas with the use of a commercial kit.
Topics: Aging; Breast Neoplasms; Bromodeoxyuridine; Carcinoma; Evaluation Studies as Topic; Female; Humans; Lymph Nodes; Middle Aged; Reagent Kits, Diagnostic; Receptors, Estrogen; Receptors, Progesterone | 1991 |
Cell proliferation in human tumour xenografts: measurement using antibody labelling against bromodeoxyuridine and Ki-67.
Topics: Animals; Antibodies, Monoclonal; Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Female; Humans; Immunoenzyme Techniques; Ki-67 Antigen; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Nuclear Proteins; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms | 1991 |
Inhibition of cell cycle kinetics and proliferation by the androgen 5 alpha-dihydrotestosterone and antiestrogen N,n-butyl-N-methyl-11-[16' alpha-chloro-3',17 beta-dihydroxy-estra-1',3',5'-(10')triene-7' alpha-yl] undecanamide in human breast cancer ZR-75
Topics: Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Division; Dihydrotestosterone; Estradiol; Estrogen Antagonists; Female; Humans; Interphase; Tumor Cells, Cultured | 1991 |
Proliferation of normal breast epithelial cells as shown by in vivo labeling with bromodeoxyuridine.
Topics: Adult; Aged; Aging; Breast; Breast Neoplasms; Bromodeoxyuridine; Cell Division; Cell Nucleus; Epithelial Cells; Female; Humans; Immunoenzyme Techniques; Menstrual Cycle; Middle Aged; Reference Values; Tissue Distribution | 1991 |
Estrogen and progesterone receptor expression and proliferation in breast cancer cells, studied with flow cytometry.
Topics: Antibodies, Monoclonal; Breast Neoplasms; Bromodeoxyuridine; Cell Transformation, Neoplastic; DNA, Neoplasm; Female; Flow Cytometry; Humans; Immunohistochemistry; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured | 1990 |
Manipulation of cell cycle kinetics: influence on the cytotoxicity of doxorubicin in human breast cancer cells.
Topics: Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; DNA; Doxorubicin; Estradiol; Female; Flow Cytometry; Humans; Insulin; Kinetics; Receptors, Estrogen; Tumor Cells, Cultured | 1990 |
Selective inhibition of thymidine kinase isoenzymes by (E)-5-(2-bromovinyl)-2-deoxyuridine.
Topics: Animals; Breast Neoplasms; Bromodeoxyuridine; Humans; Isoenzymes; Leukemia; Leukocytes, Mononuclear; Thymidine Kinase | 1990 |
Impact of flow cytometry on predicting recurrence and survival in breast cancer patients.
Topics: Analysis of Variance; Aneuploidy; Breast Neoplasms; Bromodeoxyuridine; Carcinoma, Small Cell; Cell Cycle; Cell Line; DNA; Female; Flow Cytometry; Humans; Interphase; Lung Neoplasms; Lymph Nodes; Multiple Myeloma; Neoplasm Recurrence, Local; Prognosis; Receptors, Estrogen; Receptors, Progesterone; RNA; Thymidine | 1985 |
[Intracellular localization of halogenated drugs or molecules in cultured tumor cells. A study using ionic microscopy associated with an imaging processing system].
Topics: Breast Neoplasms; Bromodeoxyuridine; Cells, Cultured; Female; Floxuridine; Humans; Image Processing, Computer-Assisted; Thymidine; Trifluridine | 1989 |
In vitro immunohistochemical localization of S-phase cells by a monoclonal antibody to bromodeoxyuridine.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Breast Neoplasms; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Nucleus; Head and Neck Neoplasms; Humans; Immunohistochemistry; In Vitro Techniques; Interphase; Lymphoma; Neoplasms | 1989 |
Cell kinetics of human tumors by in vitro bromodeoxyuridine labeling.
Topics: Breast Neoplasms; Bromodeoxyuridine; Cell Nucleus; Cell Transformation, Neoplastic; DNA, Neoplasm; Flow Cytometry; Humans; Immunohistochemistry; Interphase; Time Factors | 1989 |
Cell cycle synchronization induced by tamoxifen and 17 beta-estradiol on MCF-7 cells using flow cytometry and a monoclonal antibody against bromodeoxyuridine.
Topics: Antibodies, Monoclonal; Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; DNA; Estradiol; Female; Flow Cytometry; Humans; Tamoxifen; Time Factors; Tumor Cells, Cultured | 1988 |
The use of FITC-conjugated monoclonal antibodies for determination of S-phase cells with fluorescence microscopy.
Topics: Antibodies, Monoclonal; Autoradiography; Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Fluorescein-5-isothiocyanate; Fluoresceins; Fluorescent Antibody Technique; Humans; Interphase; Lymphocytes; Monocytes; Purpura, Thrombocytopenic; Thiocyanates | 1985 |
[Chemotherapy of metastatic brain tumors, with special reference to continuous intracranial infusion of mitomycin C and a radiosensitizer, BUdR].
Topics: Adult; Brain Neoplasms; Breast Neoplasms; Bromodeoxyuridine; Female; Humans; Injections, Spinal; Lung Neoplasms; Male; Middle Aged; Mitomycins; Neoplasm Metastasis; Radiation-Sensitizing Agents | 1971 |